The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFiske Regulatory News (FKE)

Share Price Information for Fiske (FKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 75.00
Bid: 70.00
Ask: 80.00
Change: 0.00 (0.00%)
Spread: 10.00 (14.286%)
Open: 75.00
High: 75.00
Low: 75.00
Prev. Close: 75.00
FKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

1 Oct 2018 07:00

RNS Number : 4131C
Fiske PLC
01 October 2018
 

1 October 2018

 

Fiske Plc

('Fiske' or 'the Company')

Directorate Change

The Directors of Fiske plc (the Company) are pleased to announce that, Tony Pattison has been appointed a Director of the Company with effect from 1 October 2018.

Tony Pattison is a Chartered Fellow of the Chartered Institute of Securities and Investment. During a City career spanning five decades, he has been actively involved at senior director level in the management of a number of investment companies including Fieldings Investment Management Limited ("Fieldings"), which was acquired by Fiske plc in 2017. Until his retirement from the board in 2015 he was Chairman of Capital Gearing Trust plc. He continues to personally manage private client, charity and institute portfolios.

Tony Robert Pattison, age 67, is, or has been, a director or partner of the following companies and partnerships during the past five years.

Current directorships and partnerships

Past directorships and partnerships

Fielding Investment Management Limited

Capital Gearing Trust plc

Mr Pattison currently holds 263,884 ordinary shares of 25p each in the Company ("Fiske Ordinary Shares") which represent 2.27% of the Company's total voting rights.

Mr Pattison was a shareholder in Fieldings with an interest of 6.26%. Pursuant to a Sale and Purchase Agreement (see announcements dated 27 July 2017 and 31 August 2018), Fiske has acquired the whole of the issued share capital of Fieldings. Under the terms of the Sale and Purchase Agreement, the shareholders of Fieldings, including Mr Pattison, may be due additional consideration which may be satisfied partially in the form of Fiske Ordinary Shares.

Mr Pattison was a Director of Capel-Cure Myers Capital Management Limited (CCM) until the end of 2000. Following a hearing in 1994, CCM was severely reprimanded by the Securities and Futures Authority (SFA) in Board Notice 446 on 20 October 1997 and ordered to pay a fine for inadequate custody administration and record keeping in connection with the management of part of the Mirror Group Pension Scheme investment portfolio. Mr Pattison was deemed by the SFA to be the person with overall responsibility for all aspects of the discretionary management of the portfolio. Mr Pattison received a reprimand but no fine. The Company confirms there is no other information that is required to be disclosed pursuant to Schedule 2 paragraph (g) of the AIM Rules.

For further information please contact:

• Samantha Harrison / Harrison Clarke, Grant Thornton UK LLP (Nominated Adviser)

(tel: 020 7383 5100)

• Gerard Luchini, Fiske Plc - Company Secretary

(tel: 020 7448 4700)

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKMGZLKRDGRZM
Date   Source Headline
15th Apr 20244:27 pmRNSDirector Dealing
6th Mar 202411:51 amRNSDirector Dealing
22nd Feb 20241:21 pmRNSDirector Dealing
19th Feb 20244:38 pmRNSDirector Dealing
16th Feb 20242:47 pmRNSDirector Dealing
16th Feb 20247:00 amRNSInterim results
8th Dec 20234:56 pmRNSDirector Dealing
28th Nov 20233:38 pmRNSDirector Dealing
23rd Nov 202312:52 pmRNSResult of AGM and Confirmation of Board Changes
30th Oct 20233:42 pmRNSDirector Dealing
24th Oct 20237:00 amRNSFinal Results, Annual Report and Notice of AGM
22nd Aug 20231:19 pmRNSDirector dealing
6th Jul 20237:00 amRNSDirector Dealing
31st May 20233:27 pmRNSDirector Dealing
4th Apr 202312:38 pmRNSDirector Dealing
3rd Apr 202310:55 amRNSDirector Dealing
3rd Apr 20237:00 amRNSAcquisition of Client Book
2nd Mar 20237:00 amRNSInterim results
29th Nov 20221:58 pmRNSDirector Dealings
24th Nov 20225:31 pmRNSResult of AGM
20th Oct 20227:00 amRNSFinal Results, Annual Report and Notice of AGM
18th Aug 20229:30 amRNSHolding(s) in Company
17th Jun 20224:13 pmRNSDirector Dealing
1st Mar 20227:00 amRNSHalf-year Report
17th Dec 20214:47 pmRNSDirector Dealing
10th Dec 20217:00 amRNSChange to Accounting Year End
30th Nov 20217:00 amRNSChange of Registered Office
25th Oct 202110:56 amRNSResult of AGM
30th Sep 202111:23 amRNSTotal Voting Rights
29th Sep 20215:29 pmRNSDirector Dealing
17th Sep 20211:08 pmRNSDirector Shareholding & Director Dealing
17th Sep 20219:58 amRNSExercise of Share Options and Issue of Equity
14th Sep 20219:44 amRNSFinal Results, Annual Report and Notice of AGM
5th Jul 202112:56 pmRNSHolding(s) in Company
28th May 20214:21 pmRNSDirector Dealings and Director Shareholding Update
20th Apr 20217:00 amRNSDirector Shareholding Disclosure
19th Feb 20217:00 amRNSInterim Results
8th Feb 20215:28 pmRNSForm 8.3 - Marston's PLC
23rd Dec 20202:46 pmRNSResult of AGM
3rd Dec 202010:01 amRNSDirector Dealing
30th Nov 202012:20 pmRNSIssue of Equity
30th Nov 20207:00 amRNSFinal Results, Posting of Report and Notice of AGM
16th Nov 20207:30 amRNSSale of Euroclear shares
12th Nov 202011:31 amRNSSale of Euroclear shares
22nd Sep 20202:41 pmRNSForm 8.3 - Deltic Energy Plc
27th Jul 20203:54 pmRNSForm 8.3 - Deltic Energy Plc
16th Jul 20207:00 amRNSDirector Retirement
8th Apr 20207:00 amRNSCovid-19 and Trading Update
10th Mar 20209:57 amRNSDirector Dealing
26th Feb 20207:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.